US2019175660A1PendingUtilityA1
Compositions of Ascorbic Acid and Bone Morphogenetic Protein 4 (BMP-4) for Cell Growth and Uses Related Thereto
Est. expiryNov 5, 2034(~8.3 yrs left)· nominal 20-yr term from priority
C12N 2500/38A61K 35/33C12N 15/113A61K 38/1875C12N 2310/141C12N 2506/1307A61K 31/375C12N 5/0657C12N 2320/31C12N 2501/65C12N 2501/155
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This disclosure relates to compositions comprising ascorbic acid and bone morphogenetic protein 4 (BMP-4) for growing cells and making tissues. In certain embodiments, this disclosure relates to methods of creating cardio-mimetic tissues (CMTs) by culturing the cells in the presence of ascorbic acid and bone morphogenetic protein 4 and optionally inserting into cells a muscle specific microRNA or related nucleobase polymer and under conditions such that a cardio-mimetic tissue is formed that is capable of spontaneously contracting.
Claims
exact text as granted — not AI-modified1 . A non-naturally occurring nucleobase polymer comprising or consisting essentially of a nucleotide sequence selected from: 1-134 or variant thereof.
2 . The non-naturally occurring nucleobase polymer of claim 1 which is non-naturally occurring because it contains at least one sugar modification, phosphate modification, nucleotide base modification.Join the waitlist — get patent alerts
Track US2019175660A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.